{"id":"https://openalex.org/W1970820682","doi":"https://doi.org/10.1016/j.nmd.2012.06.164","title":"T.P.45 An ongoing phase 2a study to investigate drug\u2013drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alpha glucosidase in subjects with Pompe disease \u2013 Preliminary results","display_name":"T.P.45 An ongoing phase 2a study to investigate drug\u2013drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alpha glucosidase in subjects with Pompe disease \u2013 Preliminary results","publication_year":2012,"publication_date":"2012-08-30","ids":{"openalex":"https://openalex.org/W1970820682","doi":"https://doi.org/10.1016/j.nmd.2012.06.164","mag":"1970820682"},"language":"en","primary_location":{"id":"doi:10.1016/j.nmd.2012.06.164","doi":"https://doi.org/10.1016/j.nmd.2012.06.164","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.nmd.2012.06.164","pdf_url":null,"source":{"id":"https://openalex.org/S50004817","display_name":"Neuromuscular Disorders","issn_l":"0960-8966","issn":["0960-8966","1873-2364"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuromuscular Disorders","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037775852","display_name":"Priya Sunil Kishnani","orcid":"https://orcid.org/0000-0001-8251-909X","observed_orcids":["https://orcid.org/0000-0001-8251-909X"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Kishnani","raw_affiliation_strings":["Duke University Medical Center Durham NC United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center Durham NC United States","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020091796","display_name":"Mark Andrew Tarnopolsky","orcid":"https://orcid.org/0000-0003-0312-3746","observed_orcids":["https://orcid.org/0000-0003-0312-3746"]},"institutions":[{"id":"https://openalex.org/I98251732","display_name":"McMaster University","ror":"https://ror.org/02fa3aq29","country_code":"CA","type":"education","lineage":["https://openalex.org/I98251732"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"M. Tarnopolsky","raw_affiliation_strings":["McMaster University Medical Center, Hamilton, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"McMaster University Medical Center, Hamilton, ON, Canada","institution_ids":["https://openalex.org/I98251732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108312472","display_name":"Kogileshwari Sivakumar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Sivakumar","raw_affiliation_strings":["Neuromuscular Research Center, Scottsdale, AZ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuromuscular Research Center, Scottsdale, AZ, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072518895","display_name":"Barry J. Byrne","orcid":"https://orcid.org/0000-0002-7302-1756","observed_orcids":["https://orcid.org/0000-0002-7302-1756"]},"institutions":[{"id":"https://openalex.org/I2800717037","display_name":"University of Florida Health","ror":"https://ror.org/04tk2gy88","country_code":"US","type":"education","lineage":["https://openalex.org/I2800717037","https://openalex.org/I33213144"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Byrne","raw_affiliation_strings":["University of Florida, Department of Pediatrics, Gainesville, FL, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Department of Pediatrics, Gainesville, FL, United States","institution_ids":["https://openalex.org/I2800717037","https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067876029","display_name":"\u00d6zlem G\u00f6ker-Alpan","orcid":"https://orcid.org/0000-0003-4758-6793","observed_orcids":["https://orcid.org/0000-0003-4758-6793"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O. Goker-Alpan","raw_affiliation_strings":["LSD Treatment and Research Center, CFCT, Springfield, VA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LSD Treatment and Research Center, CFCT, Springfield, VA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005125447","display_name":"K. Guter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158180","display_name":"Great Falls Clinic","ror":"https://ror.org/050fnhx85","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210158180"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Guter","raw_affiliation_strings":["Great Falls Clinic, LLP, Great Falls, MT, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Great Falls Clinic, LLP, Great Falls, MT, United States","institution_ids":["https://openalex.org/I4210158180"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Pervaiz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Pervaiz","raw_affiliation_strings":["Emory University, Decatur, GA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University, Decatur, GA, United States","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024492632","display_name":"Majed Dasouki","orcid":"https://orcid.org/0000-0003-2770-3948","observed_orcids":["https://orcid.org/0000-0003-2770-3948"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Dasouki","raw_affiliation_strings":["Univ of Kansas Medical Center Kansas City KS United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Kansas Medical Center Kansas City KS United States","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113439377","display_name":"T. Levine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140312","display_name":"Phoenix Neurological Associates","ror":"https://ror.org/04hk0mm26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210140312"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Levine","raw_affiliation_strings":["Phoenix Neurological Associates, LTD, Phoenix, AZ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phoenix Neurological Associates, LTD, Phoenix, AZ, United States","institution_ids":["https://openalex.org/I4210140312"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109214473","display_name":"Mark Roberts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111611","display_name":"Salford Royal Hospital","ror":"https://ror.org/027rkpb34","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111611","https://openalex.org/I4405259061"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M. Roberts","raw_affiliation_strings":["Salford Royal NHS Trust Hope Hospital, Salford, England, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Salford Royal NHS Trust Hope Hospital, Salford, England, United Kingdom","institution_ids":["https://openalex.org/I4210111611"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112068777","display_name":"Franklin K. Johnson","orcid":"https://orcid.org/0000-0002-5426-8171","observed_orcids":["https://orcid.org/0000-0002-5426-8171"]},"institutions":[{"id":"https://openalex.org/I4210134439","display_name":"Amicus Therapeutics (United States)","ror":"https://ror.org/0328xw886","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134439"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F.K. Johnson","raw_affiliation_strings":["Amicus Therapeutics, Cranbury, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amicus Therapeutics, Cranbury, NJ, United States","institution_ids":["https://openalex.org/I4210134439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113575888","display_name":"Sheela Sitaraman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134439","display_name":"Amicus Therapeutics (United States)","ror":"https://ror.org/0328xw886","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134439"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Sitaraman","raw_affiliation_strings":["Amicus Therapeutics, Cranbury, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amicus Therapeutics, Cranbury, NJ, United States","institution_ids":["https://openalex.org/I4210134439"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Khanna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134439","display_name":"Amicus Therapeutics (United States)","ror":"https://ror.org/0328xw886","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134439"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Khanna","raw_affiliation_strings":["Amicus Therapeutics, Cranbury, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amicus Therapeutics, Cranbury, NJ, United States","institution_ids":["https://openalex.org/I4210134439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111695569","display_name":"John J. Flanagan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134439","display_name":"Amicus Therapeutics (United States)","ror":"https://ror.org/0328xw886","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134439"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Flanagan","raw_affiliation_strings":["Amicus Therapeutics, Cranbury, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amicus Therapeutics, Cranbury, NJ, United States","institution_ids":["https://openalex.org/I4210134439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023228246","display_name":"Eric R. Sjoberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134439","display_name":"Amicus Therapeutics (United States)","ror":"https://ror.org/0328xw886","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134439"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E.R. Sjoberg","raw_affiliation_strings":["Amicus Therapeutics, Cranbury, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amicus Therapeutics, Cranbury, NJ, United States","institution_ids":["https://openalex.org/I4210134439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035296804","display_name":"Kenneth J. Valenzano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134439","display_name":"Amicus Therapeutics (United States)","ror":"https://ror.org/0328xw886","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134439"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K.J. Valenzano","raw_affiliation_strings":["Amicus Therapeutics, Cranbury, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amicus Therapeutics, Cranbury, NJ, United States","institution_ids":["https://openalex.org/I4210134439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036564166","display_name":"David J. Lockhart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134439","display_name":"Amicus Therapeutics (United States)","ror":"https://ror.org/0328xw886","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134439"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D.J. Lockhart","raw_affiliation_strings":["Amicus Therapeutics, Cranbury, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amicus Therapeutics, Cranbury, NJ, United States","institution_ids":["https://openalex.org/I4210134439"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057063044","display_name":"Pol F. Boudes","orcid":"https://orcid.org/0000-0002-8654-0352","observed_orcids":["https://orcid.org/0000-0002-8654-0352"]},"institutions":[{"id":"https://openalex.org/I4210134439","display_name":"Amicus Therapeutics (United States)","ror":"https://ror.org/0328xw886","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134439"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Boudes","raw_affiliation_strings":["Amicus Therapeutics, Cranbury, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amicus Therapeutics, Cranbury, NJ, United States","institution_ids":["https://openalex.org/I4210134439"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3470,"currency":"USD","value_usd":3470},"apc_paid":null,"fwci":0.4805,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.62028047,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"22","issue":"9-10","first_page":"852","last_page":"852"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12604","display_name":"Glycogen Storage Diseases and Myoclonus","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11027","display_name":"Metabolism and Genetic Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pompe-disease","display_name":"Pompe disease","score":0.996999979019165},{"id":"https://openalex.org/keywords/acid-alpha-glucosidase","display_name":"acid alpha-glucosidase","score":0.9240000247955322},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7609999775886536},{"id":"https://openalex.org/keywords/pharmacological-chaperones","display_name":"pharmacological chaperones","score":0.8650000095367432},{"id":"https://openalex.org/keywords/enzyme-replacement-therapy","display_name":"enzyme replacement therapy","score":0.8270000219345093},{"id":"https://openalex.org/keywords/single-ascending-dose","display_name":"single ascending dose","score":0.7549999952316284},{"id":"https://openalex.org/keywords/pharmacokinetic-interactions","display_name":"pharmacokinetic interactions","score":0.8050000071525574},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.42500001192092896},{"id":"https://openalex.org/keywords/hexosamine","display_name":"hexosamine","score":0.578000009059906},{"id":"https://openalex.org/keywords/lysosomal-storage-disorders","display_name":"lysosomal storage disease","score":0.9139999747276306}],"concepts":[{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.7751519680023193},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5733991861343384},{"id":"https://openalex.org/C2776460385","wikidata":"https://www.wikidata.org/wiki/Q420060","display_name":"Hydrochloride","level":2,"score":0.5666572451591492},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5140610933303833},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.4779265522956848},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4456680715084076},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.27303346991539},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25886648893356323},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1062297523021698},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.07343995571136475},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.nmd.2012.06.164","doi":"https://doi.org/10.1016/j.nmd.2012.06.164","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.nmd.2012.06.164","pdf_url":null,"source":{"id":"https://openalex.org/S50004817","display_name":"Neuromuscular Disorders","issn_l":"0960-8966","issn":["0960-8966","1873-2364"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuromuscular Disorders","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2317038459","https://openalex.org/W2008287871","https://openalex.org/W2086257494","https://openalex.org/W7096873326","https://openalex.org/W4242601067","https://openalex.org/W1969361816","https://openalex.org/W2062600620","https://openalex.org/W2601310652","https://openalex.org/W2013278978","https://openalex.org/W2809465042"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}